Symbols / RGC Stock $28.40 -3.03% Regencell Bioscience Holdings Limited
RGC (Stock) Chart
About
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Stock Fundamentals
Scroll to Statements| Market Cap | 14.04B | Enterprise Value | 14.48B | Income | -3.58M | Sales | — | Book/sh | 0.01 | Cash/sh | 0.01 |
| Dividend Yield | — | Payout | 0.00% | Employees | 10 | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | 2840.12 | P/C | — | EV/EBITDA | -3921.47 | EV/Sales | — |
| Quick Ratio | 7.38 | Current Ratio | 7.39 | Debt/Eq | 11.20 | LT Debt/Eq | — | EPS (ttm) | -0.01 | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | 2026-06-02 | ROA | -33.20% | ROE | -54.81% | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 494.49M | Shs Float | 43.94M | Short Float | 1.26% |
| Short Ratio | 5.62 | Short Interest | — | 52W High | 83.60 | 52W Low | 0.72 | Beta | 2.25 | Avg Volume | 168.82K |
| Volume | 5.83K | Target Price | — | Recom | None | Prev Close | $29.29 | Price | $28.40 | Change | -3.03% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$28.40
Latest analyst target
3. DCF / Fair value
$-0.05
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$28.40
Low
—
High
—
Mean
—
News
RSS: Latest RGC news- RGCO (RGC Resources Inc.) reports steep Q1 2026 EPS miss, shares dip 1.7 percent on disappointing quarterly performance. - Seasonality - Cổng thông tin điện tử Tỉnh Sơn La Wed, 22 Apr 2026 16
- Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatility with a 52-Week Range from $0.76 to $78.00 - DirectorsTalk Interviews Mon, 20 Apr 2026 09
- Regencell Bioscience (NASDAQ:RGC) Stock Price Down 8.9% - What's Next? - MarketBeat ue, 07 Apr 2026 07
- Auditor switch at Regencell (Nasdaq: RGC) after going concern note - Stock Titan Fri, 17 Apr 2026 20
- Regencell Bioscience: Extended Lock-Up Creates Significant Upside Potential (NASDAQ:RGC) - Seeking Alpha Fri, 06 Mar 2026 08
- Regencell Bioscience (RGC) Launches US$500 Million ATM Plan Is Its Funding Strategy Shifting? - simplywall.st Sun, 05 Apr 2026 07
- This $14 Billion Meme Stock Says It Is Developing a Herbal Remedy for Autism - WSJ ue, 27 Jan 2026 08
- A Look At Regencell Bioscience Holdings (RGC) Valuation After Department Of Justice Investigation News - Yahoo Finance Fri, 06 Mar 2026 08
- Regencell (RGC) Completes 38-for-1 Stock Split - MSN Wed, 15 Apr 2026 23
- This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock) - The Motley Fool Mon, 24 Nov 2025 08
- (RGC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily Fri, 17 Apr 2026 21
- Regencell (Nasdaq: RGC) sets up $500M at-the-market share sale - Stock Titan Mon, 30 Mar 2026 07
- Regencell Bioscience (NASDAQ:RGC) Stock Price Down 7.3% - Here's Why - MarketBeat Mon, 30 Mar 2026 07
- Regencell Bioscience Holdings (RGC) Climbs 11% Over Last Week - Yahoo Finance Sat, 13 Sep 2025 07
- Regencell Bioscience (NASDAQ:RGC) Stock Price Up 32% - Should You Buy? - MarketBeat Wed, 01 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
4.74
-24.50%
|
6.27
-17.64%
|
7.62
+451.47%
|
1.38
|
| Research And Development |
|
1.07
-32.59%
|
1.58
-37.04%
|
2.51
+473.13%
|
0.44
|
| Selling General And Administration |
|
3.67
-21.77%
|
4.69
-8.10%
|
5.11
+441.40%
|
0.94
|
| Selling And Marketing Expense |
|
0.13
-52.25%
|
0.26
+939.22%
|
0.03
+1503.74%
|
0.00
|
| General And Administrative Expense |
|
3.55
-19.96%
|
4.43
-12.81%
|
5.08
+439.62%
|
0.94
|
| Salaries And Wages |
|
—
|
0.90
-40.00%
|
1.50
|
0.00
|
| Other Gand A |
|
3.55
-19.96%
|
4.43
-12.81%
|
5.08
+439.62%
|
0.94
|
| Total Expenses |
|
4.74
-24.50%
|
6.27
-17.64%
|
7.62
+451.47%
|
1.38
|
| Operating Income |
|
-4.74
+24.50%
|
-6.27
+17.64%
|
-7.62
-451.47%
|
-1.38
|
| Total Operating Income As Reported |
|
-4.74
+24.50%
|
-6.27
+17.64%
|
-7.62
-451.47%
|
-1.38
|
| EBITDA |
|
-3.99
+27.49%
|
-5.50
+21.52%
|
-7.01
-417.63%
|
-1.35
|
| Normalized EBITDA |
|
-3.99
+27.49%
|
-5.50
+21.52%
|
-7.01
-417.63%
|
-1.35
|
| Reconciled Depreciation |
|
0.75
-3.13%
|
0.77
+27.35%
|
0.60
+2184.54%
|
0.03
|
| EBIT |
|
-4.74
+24.50%
|
-6.27
+17.64%
|
-7.62
-451.47%
|
-1.38
|
| Net Income |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Pretax Income |
|
-4.36
+28.03%
|
-6.06
+20.18%
|
-7.59
-463.92%
|
-1.35
|
| Other Income Expense |
|
0.37
+76.73%
|
0.21
+810.37%
|
0.02
-32.94%
|
0.03
|
| Other Non Operating Income Expenses |
|
0.37
+76.73%
|
0.21
+810.37%
|
0.02
-32.94%
|
0.03
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-4.36
+28.03%
|
-6.06
+20.18%
|
-7.59
-463.92%
|
-1.35
|
| Net Income From Continuing Operation Net Minority Interest |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Net Income From Continuing And Discontinued Operation |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Net Income Continuous Operations |
|
-4.36
+28.03%
|
-6.06
+20.18%
|
-7.59
-463.92%
|
-1.35
|
| Minority Interests |
|
0.06
-67.90%
|
0.19
+28.66%
|
0.15
|
0.00
|
| Normalized Income |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Net Income Common Stockholders |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Diluted EPS |
|
-0.01
+26.89%
|
-0.01
+22.03%
|
-0.02
-444.52%
|
-0.00
|
| Basic EPS |
|
-0.01
+26.89%
|
-0.01
+22.03%
|
-0.02
-444.52%
|
-0.00
|
| Basic Average Shares |
|
494.49
+0.00%
|
494.49
+1.62%
|
486.62
+1.29%
|
480.40
|
| Diluted Average Shares |
|
494.49
+0.00%
|
494.49
+1.62%
|
486.62
+1.29%
|
480.40
|
| Diluted NI Availto Com Stockholders |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Line Item | Trend | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Total Assets |
|
8.44
-33.15%
|
12.62
-29.95%
|
18.02
+5197.59%
|
0.34
|
| Current Assets |
|
8.11
-30.18%
|
11.62
-29.33%
|
16.44
+24499.61%
|
0.07
|
| Cash Cash Equivalents And Short Term Investments |
|
7.96
-31.16%
|
11.56
-29.56%
|
16.42
+27532.00%
|
0.06
|
| Cash And Cash Equivalents |
|
2.96
+89.24%
|
1.56
-75.61%
|
6.42
+10700.66%
|
0.06
|
| Cash Financial |
|
2.96
+89.24%
|
1.56
-75.61%
|
6.42
+10700.66%
|
0.06
|
| Other Short Term Investments |
|
5.00
-50.00%
|
10.00
+0.00%
|
10.00
|
0.00
|
| Receivables |
|
0.15
+170.17%
|
0.06
+104.90%
|
0.03
+271.14%
|
0.01
|
| Other Receivables |
|
0.15
+170.17%
|
0.06
+104.90%
|
0.03
+271.14%
|
0.01
|
| Prepaid Assets |
|
—
|
—
|
0.03
+271.14%
|
0.01
|
| Total Non Current Assets |
|
0.32
-67.59%
|
1.00
-36.45%
|
1.57
+476.07%
|
0.27
|
| Net PPE |
|
0.23
-74.60%
|
0.89
-38.91%
|
1.46
+1683.45%
|
0.08
|
| Gross PPE |
|
1.01
-26.12%
|
1.37
-16.89%
|
1.65
+1296.96%
|
0.12
|
| Accumulated Depreciation |
|
-0.78
-64.68%
|
-0.48
-155.84%
|
-0.19
-417.40%
|
-0.04
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.30
+2.21%
|
0.30
-0.54%
|
0.30
|
0.00
|
| Other Properties |
|
0.08
-81.21%
|
0.45
-39.65%
|
0.75
|
—
|
| Leases |
|
0.62
+0.38%
|
0.62
+3.31%
|
0.60
+410.47%
|
0.12
|
| Non Current Deferred Assets |
|
—
|
—
|
0.00
-100.00%
|
0.17
|
| Non Current Prepaid Assets |
|
0.10
-9.97%
|
0.11
-5.08%
|
0.11
+498.25%
|
0.02
|
| Total Liabilities Net Minority Interest |
|
0.22
-65.28%
|
0.63
-32.59%
|
0.94
-78.38%
|
4.34
|
| Current Liabilities |
|
0.19
-68.10%
|
0.61
+5.05%
|
0.58
-86.68%
|
4.34
|
| Payables And Accrued Expenses |
|
0.13
-20.68%
|
0.17
+1.12%
|
0.17
-74.57%
|
0.66
|
| Payables |
|
0.01
-20.12%
|
0.01
-32.46%
|
0.02
-81.10%
|
0.08
|
| Current Accrued Expenses |
|
0.13
-20.72%
|
0.16
+4.60%
|
0.15
-73.62%
|
0.57
|
| Current Debt And Capital Lease Obligation |
|
0.06
-86.35%
|
0.44
+6.64%
|
0.41
-88.84%
|
3.68
|
| Current Debt |
|
—
|
—
|
—
|
3.68
|
| Other Current Borrowings |
|
—
|
—
|
—
|
3.68
|
| Current Capital Lease Obligation |
|
0.06
-86.35%
|
0.44
+6.64%
|
0.41
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
0.03
+2.08%
|
0.03
-92.95%
|
0.36
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.03
+2.08%
|
0.03
-92.95%
|
0.36
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.03
+2.08%
|
0.03
-92.95%
|
0.36
|
0.00
|
| Stockholders Equity |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Common Stock Equity |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Capital Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+30.00%
|
0.00
|
| Common Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+30.00%
|
0.00
|
| Share Issued |
|
494.49
+0.00%
|
494.49
+0.00%
|
494.49
+2.93%
|
480.40
|
| Ordinary Shares Number |
|
494.49
+0.00%
|
494.49
+0.00%
|
494.49
+2.93%
|
480.40
|
| Additional Paid In Capital |
|
29.88
+1.53%
|
29.43
+3.24%
|
28.51
+11136346.88%
|
0.00
|
| Retained Earnings |
|
-21.62
-24.84%
|
-17.32
-51.30%
|
-11.44
-186.24%
|
-4.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.05
+47.19%
|
-0.09
|
0.00
|
—
|
| Minority Interest |
|
0.00
+100.00%
|
-0.04
-365.78%
|
0.02
|
0.00
|
| Other Equity Adjustments |
|
-0.05
+47.19%
|
-0.09
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
8.22
-31.45%
|
11.99
-29.81%
|
17.08
+527.27%
|
-4.00
|
| Total Capitalization |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Working Capital |
|
7.92
-28.09%
|
11.01
-30.58%
|
15.87
+471.51%
|
-4.27
|
| Invested Capital |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+5506.15%
|
-0.32
|
| Total Debt |
|
0.09
-81.51%
|
0.46
-39.88%
|
0.77
-79.05%
|
3.68
|
| Net Debt |
|
—
|
—
|
—
|
3.62
|
| Capital Lease Obligations |
|
0.09
-81.51%
|
0.46
-39.88%
|
0.77
|
0.00
|
| Net Tangible Assets |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Tangible Book Value |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Dueto Related Parties Current |
|
0.01
-20.12%
|
0.01
-32.46%
|
0.02
-81.10%
|
0.08
|
| Line Item | Trend | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.00
+19.37%
|
-4.96
+5.77%
|
-5.27
-586.43%
|
-0.77
|
| Cash Flow From Continuing Operating Activities |
|
-4.00
+19.37%
|
-4.96
+5.77%
|
-5.27
-586.43%
|
-0.77
|
| Net Income From Continuing Operations |
|
-4.36
+28.03%
|
-6.06
+20.18%
|
-7.59
-463.92%
|
-1.35
|
| Depreciation Amortization Depletion |
|
0.75
-3.13%
|
0.77
+27.35%
|
0.60
+2184.54%
|
0.03
|
| Depreciation |
|
0.75
-3.13%
|
0.77
+27.35%
|
0.60
+2184.54%
|
0.03
|
| Depreciation And Amortization |
|
0.75
-3.13%
|
0.77
+27.35%
|
0.60
+2184.54%
|
0.03
|
| Other Non Cash Items |
|
-0.25
-190.40%
|
-0.09
-695.68%
|
-0.01
|
—
|
| Stock Based Compensation |
|
0.45
-51.30%
|
0.92
-66.55%
|
2.76
|
0.00
|
| Operating Gains Losses |
|
—
|
0.00
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.00
|
0.00
|
0.00
|
| Change In Working Capital |
|
-0.59
-15.02%
|
-0.51
+50.30%
|
-1.02
-285.19%
|
0.55
|
| Change In Prepaid Assets |
|
-0.09
-269.01%
|
-0.02
+77.88%
|
-0.10
-1237.23%
|
-0.01
|
| Change In Payables And Accrued Expense |
|
-0.03
-1961.26%
|
0.00
+100.38%
|
-0.49
-187.20%
|
0.56
|
| Change In Accrued Expense |
|
-0.03
-571.00%
|
0.01
+101.65%
|
-0.42
-188.26%
|
0.48
|
| Change In Payable |
|
-0.00
+58.13%
|
-0.01
+92.44%
|
-0.07
-181.10%
|
0.08
|
| Change In Other Current Liabilities |
|
-0.47
+4.63%
|
-0.49
-13.30%
|
-0.43
|
0.00
|
| Investing Cash Flow |
|
5.24
+8789.12%
|
0.06
+100.55%
|
-10.78
|
0.00
|
| Cash Flow From Continuing Investing Activities |
|
5.24
+8789.12%
|
0.06
+100.55%
|
-10.78
|
0.00
|
| Net PPE Purchase And Sale |
|
-0.01
+79.65%
|
-0.03
+96.62%
|
-0.78
|
0.00
|
| Purchase Of PPE |
|
-0.01
+80.37%
|
-0.03
+96.49%
|
-0.78
|
0.00
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.00
|
0.00
|
0.00
|
| Capital Expenditure |
|
-0.01
+80.37%
|
-0.03
+96.49%
|
-0.78
|
—
|
| Net Investment Purchase And Sale |
|
5.25
+6045.20%
|
0.09
+100.85%
|
-10.00
|
0.00
|
| Purchase Of Investment |
|
-5.00
+50.00%
|
-10.00
+0.00%
|
-10.00
|
0.00
|
| Sale Of Investment |
|
10.25
+1.61%
|
10.09
|
0.00
|
0.00
|
| Financing Cash Flow |
|
0.10
-24.19%
|
0.13
-99.40%
|
22.41
+4995.12%
|
0.44
|
| Cash Flow From Continuing Financing Activities |
|
0.10
-24.19%
|
0.13
-99.40%
|
22.41
+4995.12%
|
0.44
|
| Net Issuance Payments Of Debt |
|
0.00
|
0.00
+100.00%
|
-0.43
-170.58%
|
0.61
|
| Issuance Of Debt |
|
—
|
—
|
—
|
0.61
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
0.61
|
| Net Short Term Debt Issuance |
|
0.00
|
0.00
+100.00%
|
-0.43
-170.58%
|
0.61
|
| Net Common Stock Issuance |
|
0.00
|
0.00
-100.00%
|
22.67
|
0.00
|
| Net Other Financing Charges |
|
0.10
-24.19%
|
0.13
-17.74%
|
0.16
+195.18%
|
-0.17
|
| Changes In Cash |
|
1.34
+128.17%
|
-4.77
-175.01%
|
6.36
+2040.86%
|
-0.33
|
| Effect Of Exchange Rate Changes |
|
0.05
+164.01%
|
-0.08
|
0.00
|
0.00
|
| Beginning Cash Position |
|
1.56
-75.61%
|
6.42
+10700.66%
|
0.06
-84.65%
|
0.39
|
| End Cash Position |
|
2.96
+89.24%
|
1.56
-75.61%
|
6.42
+10700.66%
|
0.06
|
| Free Cash Flow |
|
-4.01
+19.70%
|
-4.99
+17.49%
|
-6.05
-688.20%
|
-0.77
|
| Interest Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
0.00
|
0.00
-100.00%
|
22.67
|
0.00
|
| Issuance Of Capital Stock |
|
0.00
|
0.00
-100.00%
|
22.67
|
0.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|